News

Today Sponge is constructed of soft polyurethane foam containing a well-known, locally acting, non-systemic spermicide, N-9, the company said. The manufacturing process involves both sponge creation and active

The combined company will have a major presence in key growth markets and exceptional technical capabilities in the areas of genetic analysis, proteomics, cell biology and cell systems.

The Indian Drug Manufacturers Association (IDMA) has requested the drug price regulator to increase the prices of bulk drugs citing the depreciation in rupee value and hike in

Patients with acute lymphoblastic leukemia (ALL) are initially treated with complex and highly toxic chemotherapy regimens, which may be followed by bone marrow stem cell transplantation for eligible

Itero and Biological E will collaborate to obtain worldwide approvals and commercialize jointly developed biopharmaceuticals. Itero will be responsible for financing the development of the drug candidates, while

Dr Cone has accepted the position of chairman of the department of molecular physiology and biophysics at Vanderbilt University Medical Center, starting in August, but will continue as

The patent grants EntreMed composition-of-matter and method of use intellectual property protection through 2025 for analogs of 2- methoxyestradiol (2ME2) in oncology and a broad range of non-oncology

Maxy-VII is the company’s next-generation Factor VIIa protein for the treatment of hemophilia. Patient dosing is on schedule to begin in the second half of 2008. Russell Howard,

Under the agreement, 3M will provide its patented toll-like receptor (TLR) agonist compounds to Celldex for an undisclosed licensing fee, milestones and royalties. 3M’s patented TLR immune response